drug
benzgalantamine DR
Marketedupdated 3mo agoby AlphaCognition Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying benzgalantamine DR
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 1, 2026
109 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Jul 23, 2045method-of-use (U-713)US 12551491
- Jul 23, 2045method-of-use (U-713)US 12551491
- Jul 23, 2045method-of-use (U-713)US 12551491
- Feb 26, 2044formulationUS 12208167
- Feb 26, 2044formulationUS 12208167
- Feb 26, 2044formulationUS 12208167
- Jan 13, 2042compositionUS 11795176
- Jan 13, 2042compositionUS 11795176
- Jan 13, 2042compositionUS 11795176
- Dec 1, 2026method-of-use (U-713)US 9763953109d
- Dec 1, 2026method-of-use (U-713)US 9763953109d
- Dec 1, 2026method-of-use (U-713)US 9763953109d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that